Tulane Hemophilia Treatment Ctr.
New Orleans, Louisiana, United States
Medical clinic in New Orleans, Louisiana
1430 Tulane Ave, New Orleans, LA 70112
About Tulane Hemophilia Treatment Ctr.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Tulane Hemophilia Treatment Ctr.
During the past decade, Tulane Hemophilia Treatment Ctr. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
1998-11-01
2004-05-01
Completed
16
Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer
2003-07-01
2009-08-01
Completed
57
Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
2004-06-01
2007-05-01
Completed
Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
2005-01-01
2008-08-01
Completed
151
Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
2005-07-01
2014-07-01
Completed
724
Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
2005-06-01
2013-06-01
Completed
638
Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)
2005-06-01
2010-11-01
Terminated
476
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Tulane Hemophilia Treatment Ctr."
#1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Glaxo Wellcome" with 2 trials as a collaborator, "American Thrombosis and Hemostasis Network" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Bioverativ Therapeutics Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Tulane Hemophilia Treatment Ctr.
According to Clinical.Site data, the most researched conditions in "Tulane Hemophilia Treatment Ctr." are
"HIV Infections" (6 trials), "Hemophilia A With Inhibitor" (2 trials), "Hemophilia B With Inhibitor" (2 trials), "Haemophilia A Without Inhibitor" (1 trials) and "Haemophilia B Without Inhibitor" (1 trials). Many other conditions were trialed in "Tulane Hemophilia Treatment Ctr." in a lesser frequency.
Clinical Trials Intervention Types at Tulane Hemophilia Treatment Ctr.
Most popular intervention types in "Tulane Hemophilia Treatment Ctr." are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Zidovudine" (5 trials), "Didanosine" (4 trials), "Lamivudine" (3 trials), "Stavudine" (3 trials) and "Zalcitabine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Tulane Hemophilia Treatment Ctr.
The vast majority of trials in "Tulane Hemophilia Treatment Ctr." are
12 trials for "All" genders.
Clinical Trials Status at Tulane Hemophilia Treatment Ctr.
Currently, there are NaN active trials in "Tulane Hemophilia Treatment Ctr.".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Tulane Hemophilia Treatment Ctr.,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Tulane Hemophilia Treatment Ctr., 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".